+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enteral Syringe Market Size, Share & Trends Analysis Report by Age Group (Adults and Pediatrics), End User (Hospitals, Ambulatory Surgical Centers, and Homecare), Type (Disposable and Reusable), Regional Outlook and Forecast, 2024-2031

  • PDF Icon

    Report

  • 226 Pages
  • August 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5996334
The Global Enteral Syringe Market size is expected to reach $556.9 million by 2031, rising at a market growth of 5.1% CAGR during the forecast period.

The prevalence of chronic diseases, such as cancer and cardiovascular conditions, is on the rise in the Asia-Pacific region. These conditions often require enteral feeding, increasing the demand for these syringes. Patients with chronic illnesses may need long-term nutritional support, which can be effectively managed using these syringes. Consequently, the Asia Pacific region would acquire nearly 30% of the total market share by 2031.



Adopting nutritional support therapy emphasizes personalized care tailored to individual patient needs. In addition, updated clinical guidelines and protocols now commonly include recommendations for nutritional support therapy as a standard practice for managing patients with specific health conditions. Hence, the increasing adoption of nutritional support therapy is driving the market’s growth.

Additionally, Older adults frequently experience health conditions that necessitate specialized nutritional support. Conditions such as malnutrition, dysphagia (difficulty swallowing), and chronic illnesses often require enteral feeding solutions. Additionally, chronic diseases like diabetes, heart disease, and cancer are more common among the elderly population. Thus, the growing aging population is propelling the growth of the market.

However, Healthcare facilities, particularly those operating under tight budget constraints, may struggle to justify the expenditure on advanced syringes. Patients, especially those in lower-income brackets or regions with limited healthcare funding, may have restricted access to advanced syringes due to their high cost. In conclusion, the high cost of advanced syringes hampers the market’s growth.

Moreover, the postponement of elective medical procedures and treatments during the pandemic decreased the need for these syringes in certain healthcare settings. The overwhelming pressure on healthcare facilities due to the COVID-19 crisis disrupted routine care and management of patients requiring enteral feeding. Major industry events, trade shows, and conferences were cancelled or held virtually, limiting networking and market growth opportunities. Thus, the COVID-19 had a negative impact on the market.

Driving and Restraining Factors

Drivers

  • Increasing adoption of nutritional support therapy
  • Growing aging population globally
  • Rising prevalence of chronic diseases worldwide

Restraints

  • High cost of advanced enteral syringes
  • Risk of product recalls and safety concerns

Opportunities

  • Expansion of healthcare infrastructure
  • Rising incidence of paediatric conditions

Challenges

  • Variability in patient needs and preferences
  • High competition from alternative feeding methods

Age Group Outlook

On the basis of age group, the market is segmented into adults and paediatrics. In 2023, the paediatrics segment attained 23% revenue share in the market. Advances in medical care have significantly improved the survival rates of preterm infants and children with severe health conditions, many of whom require enteral feeding.

End User Outlook

By end user, the market is divided into hospitals, ambulatory surgical centres, and homecare. The homecare segment procured a 13% revenue share in the market in 2023. As the global population ages, more elderly individuals require long-term care, including enteral feeding, which can be effectively managed at home using these syringes.



Type Outlook

Based on type, the market is divided into reusable and disposable. The reusable segment procured 37% revenue share in the market in 2023. Although reusable syringes require an initial investment, they can be more cost-effective over time than disposable syringes. For healthcare facilities with high usage rates, the cumulative cost of disposables can be significantly higher.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 35% revenue share in the market in 2022. North America boasts a sophisticated healthcare system with numerous hospitals, clinics, and long-term care facilities equipped with advanced medical technologies, including these syringes.

List of Key Companies Profiled

  • Boston Scientific Corporation
  • Nestlé S.A.
  • Fresenius SE & Co. KGaA
  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Cardinal Health, Inc.
  • Moog Inc.
  • Cook Medical, Inc.(Cook Group)
  • Thermo Fisher Scientific Inc.
  • Medela AG

Market Report Segmentation

By Age Group

  • Adults
  • Pediatrics

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare

By Type

  • Disposable
  • Reusable

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Enteral Syringe Market, by Age Group
1.4.2 Global Enteral Syringe Market, by End User
1.4.3 Global Enteral Syringe Market, by Type
1.4.4 Global Enteral Syringe Market, by Geography
1.5 Methodology for the Research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Enteral Syringe Market by Age Group
4.1 Global Adults Market by Region
4.2 Global Pediatrics Market by Region
Chapter 5. Global Enteral Syringe Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgical Centers Market by Region
5.3 Global Homecare Market by Region
Chapter 6. Global Enteral Syringe Market by Type
6.1 Global Disposable Market by Region
6.2 Global Reusable Market by Region
Chapter 7. Global Enteral Syringe Market by Region
7.1 North America Enteral Syringe Market
7.1.1 North America Enteral Syringe Market by Age Group
7.1.1.1 North America Adults Market by Region
7.1.1.2 North America Pediatrics Market by Region
7.1.2 North America Enteral Syringe Market by End User
7.1.2.1 North America Hospitals Market by Country
7.1.2.2 North America Ambulatory Surgical Centers Market by Country
7.1.2.3 North America Homecare Market by Country
7.1.3 North America Enteral Syringe Market by Type
7.1.3.1 North America Disposable Market by Country
7.1.3.2 North America Reusable Market by Country
7.1.4 North America Enteral Syringe Market by Country
7.1.4.1 US Enteral Syringe Market
7.1.4.1.1 US Enteral Syringe Market by Age Group
7.1.4.1.2 US Enteral Syringe Market by End User
7.1.4.1.3 US Enteral Syringe Market by Type
7.1.4.2 Canada Enteral Syringe Market
7.1.4.2.1 Canada Enteral Syringe Market by Age Group
7.1.4.2.2 Canada Enteral Syringe Market by End User
7.1.4.2.3 Canada Enteral Syringe Market by Type
7.1.4.3 Mexico Enteral Syringe Market
7.1.4.3.1 Mexico Enteral Syringe Market by Age Group
7.1.4.3.2 Mexico Enteral Syringe Market by End User
7.1.4.3.3 Mexico Enteral Syringe Market by Type
7.1.4.4 Rest of North America Enteral Syringe Market
7.1.4.4.1 Rest of North America Enteral Syringe Market by Age Group
7.1.4.4.2 Rest of North America Enteral Syringe Market by End User
7.1.4.4.3 Rest of North America Enteral Syringe Market by Type
7.2 Europe Enteral Syringe Market
7.2.1 Europe Enteral Syringe Market by Age Group
7.2.1.1 Europe Adults Market by Country
7.2.1.2 Europe Pediatrics Market by Country
7.2.2 Europe Enteral Syringe Market by End User
7.2.2.1 Europe Hospitals Market by Country
7.2.2.2 Europe Ambulatory Surgical Centers Market by Country
7.2.2.3 Europe Homecare Market by Country
7.2.3 Europe Enteral Syringe Market by Type
7.2.3.1 Europe Disposable Market by Country
7.2.3.2 Europe Reusable Market by Country
7.2.4 Europe Enteral Syringe Market by Country
7.2.4.1 Germany Enteral Syringe Market
7.2.4.1.1 Germany Enteral Syringe Market by Age Group
7.2.4.1.2 Germany Enteral Syringe Market by End User
7.2.4.1.3 Germany Enteral Syringe Market by Type
7.2.4.2 UK Enteral Syringe Market
7.2.4.2.1 UK Enteral Syringe Market by Age Group
7.2.4.2.2 UK Enteral Syringe Market by End User
7.2.4.2.3 UK Enteral Syringe Market by Type
7.2.4.3 France Enteral Syringe Market
7.2.4.3.1 France Enteral Syringe Market by Age Group
7.2.4.3.2 France Enteral Syringe Market by End User
7.2.4.3.3 France Enteral Syringe Market by Type
7.2.4.4 Russia Enteral Syringe Market
7.2.4.4.1 Russia Enteral Syringe Market by Age Group
7.2.4.4.2 Russia Enteral Syringe Market by End User
7.2.4.4.3 Russia Enteral Syringe Market by Type
7.2.4.5 Spain Enteral Syringe Market
7.2.4.5.1 Spain Enteral Syringe Market by Age Group
7.2.4.5.2 Spain Enteral Syringe Market by End User
7.2.4.5.3 Spain Enteral Syringe Market by Type
7.2.4.6 Italy Enteral Syringe Market
7.2.4.6.1 Italy Enteral Syringe Market by Age Group
7.2.4.6.2 Italy Enteral Syringe Market by End User
7.2.4.6.3 Italy Enteral Syringe Market by Type
7.2.4.7 Rest of Europe Enteral Syringe Market
7.2.4.7.1 Rest of Europe Enteral Syringe Market by Age Group
7.2.4.7.2 Rest of Europe Enteral Syringe Market by End User
7.2.4.7.3 Rest of Europe Enteral Syringe Market by Type
7.3 Asia Pacific Enteral Syringe Market
7.3.1 Asia Pacific Enteral Syringe Market by Age Group
7.3.1.1 Asia Pacific Adults Market by Country
7.3.1.2 Asia Pacific Pediatrics Market by Country
7.3.2 Asia Pacific Enteral Syringe Market by End User
7.3.2.1 Asia Pacific Hospitals Market by Country
7.3.2.2 Asia Pacific Ambulatory Surgical Centers Market by Country
7.3.2.3 Asia Pacific Homecare Market by Country
7.3.3 Asia Pacific Enteral Syringe Market by Type
7.3.3.1 Asia Pacific Disposable Market by Country
7.3.3.2 Asia Pacific Reusable Market by Country
7.3.4 Asia Pacific Enteral Syringe Market by Country
7.3.4.1 China Enteral Syringe Market
7.3.4.1.1 China Enteral Syringe Market by Age Group
7.3.4.1.2 China Enteral Syringe Market by End User
7.3.4.1.3 China Enteral Syringe Market by Type
7.3.4.2 Japan Enteral Syringe Market
7.3.4.2.1 Japan Enteral Syringe Market by Age Group
7.3.4.2.2 Japan Enteral Syringe Market by End User
7.3.4.2.3 Japan Enteral Syringe Market by Type
7.3.4.3 India Enteral Syringe Market
7.3.4.3.1 India Enteral Syringe Market by Age Group
7.3.4.3.2 India Enteral Syringe Market by End User
7.3.4.3.3 India Enteral Syringe Market by Type
7.3.4.4 South Korea Enteral Syringe Market
7.3.4.4.1 South Korea Enteral Syringe Market by Age Group
7.3.4.4.2 South Korea Enteral Syringe Market by End User
7.3.4.4.3 South Korea Enteral Syringe Market by Type
7.3.4.5 Singapore Enteral Syringe Market
7.3.4.5.1 Singapore Enteral Syringe Market by Age Group
7.3.4.5.2 Singapore Enteral Syringe Market by End User
7.3.4.5.3 Singapore Enteral Syringe Market by Type
7.3.4.6 Malaysia Enteral Syringe Market
7.3.4.6.1 Malaysia Enteral Syringe Market by Age Group
7.3.4.6.2 Malaysia Enteral Syringe Market by End User
7.3.4.6.3 Malaysia Enteral Syringe Market by Type
7.3.4.7 Rest of Asia Pacific Enteral Syringe Market
7.3.4.7.1 Rest of Asia Pacific Enteral Syringe Market by Age Group
7.3.4.7.2 Rest of Asia Pacific Enteral Syringe Market by End User
7.3.4.7.3 Rest of Asia Pacific Enteral Syringe Market by Type
7.4 LAMEA Enteral Syringe Market
7.4.1 LAMEA Enteral Syringe Market by Age Group
7.4.1.1 LAMEA Adults Market by Country
7.4.1.2 LAMEA Pediatrics Market by Country
7.4.2 LAMEA Enteral Syringe Market by End User
7.4.2.1 LAMEA Hospitals Market by Country
7.4.2.2 LAMEA Ambulatory Surgical Centers Market by Country
7.4.2.3 LAMEA Homecare Market by Country
7.4.3 LAMEA Enteral Syringe Market by Type
7.4.3.1 LAMEA Disposable Market by Country
7.4.3.2 LAMEA Reusable Market by Country
7.4.4 LAMEA Enteral Syringe Market by Country
7.4.4.1 Brazil Enteral Syringe Market
7.4.4.1.1 Brazil Enteral Syringe Market by Age Group
7.4.4.1.2 Brazil Enteral Syringe Market by End User
7.4.4.1.3 Brazil Enteral Syringe Market by Type
7.4.4.2 Argentina Enteral Syringe Market
7.4.4.2.1 Argentina Enteral Syringe Market by Age Group
7.4.4.2.2 Argentina Enteral Syringe Market by End User
7.4.4.2.3 Argentina Enteral Syringe Market by Type
7.4.4.3 UAE Enteral Syringe Market
7.4.4.3.1 UAE Enteral Syringe Market by Age Group
7.4.4.3.2 UAE Enteral Syringe Market by End User
7.4.4.3.3 UAE Enteral Syringe Market by Type
7.4.4.4 Saudi Arabia Enteral Syringe Market
7.4.4.4.1 Saudi Arabia Enteral Syringe Market by Age Group
7.4.4.4.2 Saudi Arabia Enteral Syringe Market by End User
7.4.4.4.3 Saudi Arabia Enteral Syringe Market by Type
7.4.4.5 South Africa Enteral Syringe Market
7.4.4.5.1 South Africa Enteral Syringe Market by Age Group
7.4.4.5.2 South Africa Enteral Syringe Market by End User
7.4.4.5.3 South Africa Enteral Syringe Market by Type
7.4.4.6 Nigeria Enteral Syringe Market
7.4.4.6.1 Nigeria Enteral Syringe Market by Age Group
7.4.4.6.2 Nigeria Enteral Syringe Market by End User
7.4.4.6.3 Nigeria Enteral Syringe Market by Type
7.4.4.7 Rest of LAMEA Enteral Syringe Market
7.4.4.7.1 Rest of LAMEA Enteral Syringe Market by Age Group
7.4.4.7.2 Rest of LAMEA Enteral Syringe Market by End User
7.4.4.7.3 Rest of LAMEA Enteral Syringe Market by Type
Chapter 8. Company Profiles
8.1 Boston Scientific Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Nestle S.A.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Fresenius SE & Co. KGaA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Becton, Dickinson, and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 B. Braun Melsungen AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Cardinal Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 SWOT Analysis
8.7 Moog, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Cook Medical, Inc. (Cook Group)
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Thermo Fisher Scientific, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Medela AG
8.10.1 Company Overview
8.10.2 SWOT Analysis
Chapter 9. Winning Imperatives for Enteral Syringe Market

Companies Mentioned

  • Boston Scientific Corporation
  • Nestlé S.A.
  • Fresenius SE & Co. KGaA
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Moog Inc.
  • Cook Medical, Inc.(Cook Group)
  • Thermo Fisher Scientific Inc.
  • Medela AG

Methodology

Loading
LOADING...

Table Information